The Body PRO covers the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2009)


Featured Coverage

Kimberly Smith, M.D., M.P.H. Virologic Suppression Is Less Likely Among Antiretroviral-Experienced, African-American Women. But Why?
A GRACE study analysis reveals that, among treatment-experienced patients, African-American women are significantly less likely than their white counterparts to achieve an undetectable viral load on HIV treatment. Lead author Kimberly Smith, M.D., M.P.H., points to two possible explanations: Black women were more likely to drop out of the study entirely, and those who remained were less likely to adhere to their therapy.
Read or listen (15 min.):
More Headlines:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The Body PRO is an independent Web site not associated with this conference. The Body PRO provides medical education and information to health care professionals.